drugset / Trial / NCT07020806
[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)
Phase 1
Recruiting
30 enrolled
University of California, Davis
Dr. Cameron Foster, University of California Davis · collabDr. Helen K Chew, University of California Davis · collabSociety of Nuclear Medicine and Molecular Imaging · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is a prospective study using \[68Ga\]Ga DOTA-5G PET/CT imaging in patients diagnosed with metastatic/advanced invasive lobular breast cancer (LBC).
Timeline
- Start
- 2025-11-18
- Primary completion
- 2027-06
- Completion
- 2027-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [68Ga]Ga DOTA-5G | Diagnostic / imaging agent | 185 mbq | — |